X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Researchers Develop Revolutionary Treatment In Bone Cancer

    Singapore Precision Drugs To Excel By Next-Gen Proteomics

    Temperature Stable TB Vaccine Gives Out Immune Response

    T Cells Are Fruitful In Thwarting-Off Chronic Infections

    Randomness Drives Tumour Cells Response To Chemotherapy

    mAbs And Therapeutic Proteins Potency Guidance Issued By FDA

    Novel Purification Means For Protein Drug Manufacturing

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Researchers Develop Revolutionary Treatment In Bone Cancer

    Singapore Precision Drugs To Excel By Next-Gen Proteomics

    Temperature Stable TB Vaccine Gives Out Immune Response

    T Cells Are Fruitful In Thwarting-Off Chronic Infections

    Randomness Drives Tumour Cells Response To Chemotherapy

    mAbs And Therapeutic Proteins Potency Guidance Issued By FDA

    Novel Purification Means For Protein Drug Manufacturing

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    Duchenne Muscular Dystrophy-Cancer Genetic Link Discovered

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Researchers Develop Revolutionary Treatment In Bone Cancer

Content Team by Content Team
10th March 2023
in News, Research & Development

Researchers from the University of East Anglia- UEA have come up with a new non-invasive treatment for bone cancer that happens to be effective against all primary forms of the disease. Notably, the current bone cancer treatment remains invasive and painful and often involves limb amputation as well as chemotherapy that is outdated. Even after procedures, the five-year survival rate for bone cancer just happens to be 42%. This is mainly due to the fact that bone cancer spreads quickly to the lungs.

Bone cancer, which tends to affect predominantly children, begins in the bones, unlike other types of cancer that might spread through the bones. As per UEA research, CADD522, the new drug, can go on to block the gene associated with the spread of bone cancer. This was evident when a mouse was implanted with human bone cancer. In most of the cases, the bone cancer causes largely remain unknown. That said, previous exposure to radiation when it comes to radiotherapy increases the disease level. It is well to be noted that the Li-Fraumeni syndrome, as well as Paget’s disease of the bones, can go on to cause the disease. However, both conditions happen to be rare.

Apparently, the study, which is titled YBX1- interacting small RNAs as well as RUNX2 can be blocked in primary bone cancer by way of using CADD522, the researchers happen to be of the opinion that CADD522 can go on to elevate the survival rates by 50% and also eradicate any sort of surgery as well as chemotherapy that is required. The best part is that the drug has no side effects that are usually associated with chemotherapy, like tiredness, hair loss, or sickness.

As per Dr. Darren Green, the lead researcher from UEA’s Norwich Medical School, primary bone cancer begins in the bones and is the third largest form of childhood cancer, right after brain and kidney. There are around 52000 new cases reported annually across the world. He added that the fact that it spreads rapidly to other body parts is the most challenging aspect of this kind of cancer. Once this cancer spreads, it becomes very cumbersome to treat it with the intent of curing it.

What’s next on the cards is that CADD522 will go through a formal toxicology assessment. The research done after this will stack all the data and approach the MHRA formally for clinical trials so as to begin their treatment of bone cancer.

Previous Post

Singapore Precision Drugs To Excel By Next-Gen Proteomics

Related Posts

Drug Development

Singapore Precision Drugs To Excel By Next-Gen Proteomics

10th March 2023
Clinical Trials

Temperature Stable TB Vaccine Gives Out Immune Response

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
News

Randomness Drives Tumour Cells Response To Chemotherapy

10th March 2023
Drug Development

mAbs And Therapeutic Proteins Potency Guidance Issued By FDA

9th March 2023
News

Pharma Responds To The Statutory Scheme Surge By The UK

9th March 2023

Latest News

News

Researchers Develop Revolutionary Treatment In Bone Cancer

10th March 2023
Drug Development

Singapore Precision Drugs To Excel By Next-Gen Proteomics

10th March 2023
Clinical Trials

Temperature Stable TB Vaccine Gives Out Immune Response

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
News

Randomness Drives Tumour Cells Response To Chemotherapy

10th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In